Skip to content

The Baby-Saver Kit: Clinical Testing of a Device for Neonatal Resuscitation With Intact Cord in Uganda

The Baby-Saver Kit: Development and Evaluation of a Novel Device for Affordable Neonatal Resuscitation in a Low-income Region in Africa

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03885492
Acronym
BabySaver
Enrollment
47
Registered
2019-03-21
Start date
2020-11-01
Completion date
2021-04-01
Last updated
2023-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Asphyxia, Maternal Distress, Neonatal Resuscitation

Brief summary

To examine the usability, safety and acceptability of the BabySaver kit: a novel device for neonatal resuscitation in a low-income region in Africa

Detailed description

The BabySaver kit will be used for any delivery in which the baby requires resuscitation according to the hospital policy, national guidelines(Ministry of Health, 2016) and WHO policy(World Health Organization, 2014) The target sample size for observation will be 30 babies requiring resuscitation at Mbale Regional Referral Hospital Delivery suite. The researchers will observe midwives and mothers during the process of resuscitation. This will be a non-participant observation. The researchers will collect data on: demographics, the timing of cord clamping, time to establish ventilation, intervention provided on the kit, post-resuscitation temperature, need to move the baby to provide extra care, and notes of the ease of use or challenges experienced with the kit. The researchers will ask health workers for their views of the usability of the kit in comparison to the equipment in current use. The researchers have developed a usability checklist to assess how health workers are using the BabySaver kit.

Interventions

None listed

Sponsors

University of Liverpool
CollaboratorOTHER
Grand Challenges Canada
CollaboratorOTHER
Mbale Regional Referral Hospital
CollaboratorOTHER
Makerere University
CollaboratorOTHER
Sanyu Africa Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* As this is the first delivery suite to use the kit in a clinical setting, we will include only low-risk babies in this study. Every low-risk birth that will need neonatal resuscitation will be selected and observations made for the use of the BabySaver resuscitation kit.

Exclusion criteria

* High risk deliveries will be excluded, namely * babies born before 34 weeks' gestation, * babies with life threatening malformations or significant intrapartum asphyxia

Design outcomes

Primary

MeasureTime frameDescription
Change from 10 minutes in post-resuscitation temperature at 30 minutesBetween 10 and 30 minutes after birthThe researcher will measure post resuscitation temperatures at 10, 20 and 30 minutes afterbirth for babies not admitted to the neonatal unit after using the BabySaver.
Number of procedures performed to newborns while on the BabySaver kitat birth, upto 30 minutesThe researcher will list any resuscitation procedures or interventions provided to the newborns on the kit.
change from childbirth in post-resuscitation temperature at admission to Neonatal unit.Upon admission to Neonatal unit, up to 1 hour after birthFor babies admitted to the neonatal unit, the baby's temperature will be measured on admission to the Neonatal unit

Secondary

MeasureTime frameDescription
change from birth in Apgar score at 5 minutesupto 5 minutesApgar score will be recorded at 1 minute and 5 minutes. Resuscitation of babies at birth will be performed in line with existing hospital guidelines.
Demographic assessmentsbaselineResearchers will collect both mother's (age, marital status, education, occupation) and baby's demographic characteristics (sex, birth weight, gestation at birth).
Design assessments transcriptsuptown 2 monthsResearchers will collect data about design and practical aspects of the BabySaver kit from mothers, carers, midwives and doctors in form of audio and video recordings and extra notes. These will be transcribed verbatim for analysis using an NVivo qualitative software.

Countries

Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026